Actively Recruiting
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Led by Vanda Pharmaceuticals · Updated on 2025-03-04
100
Participants Needed
9
Research Sites
183 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.
CONDITIONS
Official Title
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is willing and able to provide assent and willing to complete all aspects of the study
- Patient's parent or legal guardian willing and able to provide consent
- Male or female patients 12 through 17 years of age (inclusive)
- Clinical diagnosis of either schizophrenia or bipolar I disorder
You will not qualify if you...
- Use of other investigational drugs at the time of enrollment, or within 30 days or 5 half-lives of enrollment, whichever is longer
- A positive test for drugs of abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
Vanda Investigational Site
Little Rock, Arkansas, United States, 72204
Actively Recruiting
2
Vanda Investigational Site
Denver, Colorado, United States, 80202
Actively Recruiting
3
Vanda Investigational Site
Atlanta, Georgia, United States, 30318
Actively Recruiting
4
Vanda Investigational Site
Atlanta, Georgia, United States, 30331
Actively Recruiting
5
Vanda Investigational Site
Decatur, Georgia, United States, 30030
Actively Recruiting
6
Vanda Investigational Site
Cincinnati, Ohio, United States, 45221
Actively Recruiting
7
Vanda Investigational Site
Garfield Heights, Ohio, United States, 44125
Actively Recruiting
8
Vanda Investigational Site
Westlake, Ohio, United States, 44145
Not Yet Recruiting
9
Vanda Investigational Site
Everett, Washington, United States, 98201
Actively Recruiting
Research Team
V
Vanda Pharmaceuticals Inc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here